Skip to main content
Top
Published in: Pituitary 2/2013

01-06-2013

Prevalence of cerebral aneurysm in patients with acromegaly

Authors: Satoru Oshino, Akio Nishino, Tsuyoshi Suzuki, Hideyuki Arita, Akihiro Tateishi, Katsumi Matsumoto, Toshio Shimokawa, Manabu Kinoshita, Toshiki Yoshimine, Youichi Saitoh

Published in: Pituitary | Issue 2/2013

Login to get access

Abstract

The prevalence of cerebral aneurysm was retrospectively investigated in 208 patients with acromegaly relative to the rate of cerebral aneurysm in a group of control subjects. Neuroradiological examinations of the cerebral vascular system were conducted in 208 acromegaly patients (101 men; mean age, 48.8 years). The prevalence of cerebral aneurysm in the acromegaly patients was compared to that in a control group consisting of 7,390 subjects who underwent “brain checkup” between 2006 and 2008 (mean age, 51.6 years). In the acromegaly group, cerebral aneurysm was detected in 4.3 % of patients. By sex, the prevalence was 6.9 % in males, a significantly proportion than that in the control group with an odds ratio of 4.40. The prevalence in females did not differ between the two groups. In the acromegaly group, the rate of hypertension was significantly higher in the patients with aneurysm compared to those without aneurysm. Multiple logistic regression identified acromegaly as a significant factor related to the prevalence of cerebral aneurysm in all male subjects; other factors, such as age, hypertension and smoking, were not found to be significant. A significantly higher prevalence of cerebral aneurysm was detected in male patients with acromegaly. This finding indicates that excess growth hormone or insulin-like growth factor 1 affects the cerebral vascular wall, resulting in aneurysm formation. In addition to known systematic complications in the cardiovascular, respiratory, metabolic, and other systems, the risk of cerebral aneurysm should be considered in the management of acromegaly.
Literature
1.
go back to reference Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102–152PubMedCrossRef Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102–152PubMedCrossRef
2.
go back to reference Jakubowski J, Kendall B (1978) Coincidental aneurysms with tumours of pituitary origin. J Neurol Neurosurg Psychiatry 41(11):972–979PubMedCrossRef Jakubowski J, Kendall B (1978) Coincidental aneurysms with tumours of pituitary origin. J Neurol Neurosurg Psychiatry 41(11):972–979PubMedCrossRef
3.
go back to reference Acqui M, Ferrante L, Fraioli B, Cosentino F, Fortuna A, Mastronardi L (1987) Association between intracranial aneurysms and pituitary adenomas. A Etiopathogenetic hypotheses. Neurochirurgia (Stuttg) 30(6):177–181 Acqui M, Ferrante L, Fraioli B, Cosentino F, Fortuna A, Mastronardi L (1987) Association between intracranial aneurysms and pituitary adenomas. A Etiopathogenetic hypotheses. Neurochirurgia (Stuttg) 30(6):177–181
4.
go back to reference Pant B, Arita K, Kurisu K, Tominaga A, Eguchi K, Uozumi T (1997) Incidence of intracranial aneurysm associated with pituitary adenoma. Neurosurg Rev 20(1):13–17PubMedCrossRef Pant B, Arita K, Kurisu K, Tominaga A, Eguchi K, Uozumi T (1997) Incidence of intracranial aneurysm associated with pituitary adenoma. Neurosurg Rev 20(1):13–17PubMedCrossRef
5.
go back to reference Weir B (1992) Pituitary tumors and aneurysms: case report and review of the literature. Neurosurgery 30(4):585–591PubMedCrossRef Weir B (1992) Pituitary tumors and aneurysms: case report and review of the literature. Neurosurgery 30(4):585–591PubMedCrossRef
6.
go back to reference Zatelli MC, Scanarini M, Bondanelli M, Ambrosio MR, degli Uberti EC (2004) Cerebral aneurysm and acromegaly: a case report. J Endocrinol Invest 27(8):770–773PubMed Zatelli MC, Scanarini M, Bondanelli M, Ambrosio MR, degli Uberti EC (2004) Cerebral aneurysm and acromegaly: a case report. J Endocrinol Invest 27(8):770–773PubMed
7.
go back to reference Curto L, Squadrito S, Almoto B, Longo M, Granata F, Salpietro F, Torre ML, Marini F, Trimarchi F, Cannavo S (2007) MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case. Pituitary 10(3):299–305PubMedCrossRef Curto L, Squadrito S, Almoto B, Longo M, Granata F, Salpietro F, Torre ML, Marini F, Trimarchi F, Cannavo S (2007) MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case. Pituitary 10(3):299–305PubMedCrossRef
8.
go back to reference Manara R, Maffei P, Citton V, Rizzati S, Bommarito G, Ermani M, Albano I, Della Puppa A, Carollo C, Pavesi G, Scanarini M, Ceccato F, Sicolo N, Mantero F, Scaroni C, Martini C (2011) Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature. J Clin Endocrinol Metab 96(5):1292–1300PubMedCrossRef Manara R, Maffei P, Citton V, Rizzati S, Bommarito G, Ermani M, Albano I, Della Puppa A, Carollo C, Pavesi G, Scanarini M, Ceccato F, Sicolo N, Mantero F, Scaroni C, Martini C (2011) Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature. J Clin Endocrinol Metab 96(5):1292–1300PubMedCrossRef
9.
go back to reference Yoshimoto Y (2006) A mathematical model of the natural history of intracranial aneurysms: quantification of the benefit of prophylactic treatment. J Neurosurg 104(2):195–200PubMedCrossRef Yoshimoto Y (2006) A mathematical model of the natural history of intracranial aneurysms: quantification of the benefit of prophylactic treatment. J Neurosurg 104(2):195–200PubMedCrossRef
10.
go back to reference Tanimoto K, Hizuka N, Fukuda I, Takano K, Hanafusa T (2008) The influence of age on the GH-IGF1 axis in patients with acromegaly. Eur J Endocrinol 159(4):375–379PubMedCrossRef Tanimoto K, Hizuka N, Fukuda I, Takano K, Hanafusa T (2008) The influence of age on the GH-IGF1 axis in patients with acromegaly. Eur J Endocrinol 159(4):375–379PubMedCrossRef
11.
go back to reference Wardlaw JM, White PM (2000) The detection and management of unruptured intracranial aneurysms. Brain 123(Pt 2):205–221PubMedCrossRef Wardlaw JM, White PM (2000) The detection and management of unruptured intracranial aneurysms. Brain 123(Pt 2):205–221PubMedCrossRef
12.
go back to reference Ellamushi HE, Grieve JP, Jager HR, Kitchen ND (2001) Risk factors for the formation of multiple intracranial aneurysms. J Neurosurg 94(5):728–732PubMedCrossRef Ellamushi HE, Grieve JP, Jager HR, Kitchen ND (2001) Risk factors for the formation of multiple intracranial aneurysms. J Neurosurg 94(5):728–732PubMedCrossRef
13.
go back to reference Harrod CG, Batjer HH, Bendok BR (2006) Deficiencies in estrogen-mediated regulation of cerebrovascular homeostasis may contribute to an increased risk of cerebral aneurysm pathogenesis and rupture in menopausal and postmenopausal women. Med Hypotheses 66(4):736–756PubMedCrossRef Harrod CG, Batjer HH, Bendok BR (2006) Deficiencies in estrogen-mediated regulation of cerebrovascular homeostasis may contribute to an increased risk of cerebral aneurysm pathogenesis and rupture in menopausal and postmenopausal women. Med Hypotheses 66(4):736–756PubMedCrossRef
14.
go back to reference Horiuchi T, Tanaka Y, Hongo K (2006) Sex-related differences in patients treated surgically for aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 46(7): 328–332, discussion 332 Horiuchi T, Tanaka Y, Hongo K (2006) Sex-related differences in patients treated surgically for aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 46(7): 328–332, discussion 332
15.
go back to reference Horikoshi T, Akiyama I, Yamagata Z, Nukui H (2002) Retrospective analysis of the prevalence of asymptomatic cerebral aneurysm in 4518 patients undergoing magnetic resonance angiography–when does cerebral aneurysm develop? Neurol Med Chir (Tokyo) 42(3): 105–112, discussion 113 Horikoshi T, Akiyama I, Yamagata Z, Nukui H (2002) Retrospective analysis of the prevalence of asymptomatic cerebral aneurysm in 4518 patients undergoing magnetic resonance angiography–when does cerebral aneurysm develop? Neurol Med Chir (Tokyo) 42(3): 105–112, discussion 113
16.
go back to reference Schwab KE, Gailloud P, Wyse G, Tamargo RJ (2008) Limitations of magnetic resonance imaging and magnetic resonance angiography in the diagnosis of intracranial aneurysms. Neurosurgery 63(1): 29–34, discussion 34–25 Schwab KE, Gailloud P, Wyse G, Tamargo RJ (2008) Limitations of magnetic resonance imaging and magnetic resonance angiography in the diagnosis of intracranial aneurysms. Neurosurgery 63(1): 29–34, discussion 34–25
17.
go back to reference Kulseng B, Myhre HO (2006) Is insulin growth factor-1 (IGF-1) playing a role for aneurysm formation in patients with pituitary gland tumor? Int Angiol 25(4):433–435PubMed Kulseng B, Myhre HO (2006) Is insulin growth factor-1 (IGF-1) playing a role for aneurysm formation in patients with pituitary gland tumor? Int Angiol 25(4):433–435PubMed
18.
go back to reference Maffei P, Menegazzo C, Michelotto M, Salmaso R, Martini C, De Carlo E, Carli M, Barban M, Fassina A, Vettor R, Sicolo N (2008) Sudden death due to aortic rupture in acromegaly. Heart Vessels 23(1):71–74PubMedCrossRef Maffei P, Menegazzo C, Michelotto M, Salmaso R, Martini C, De Carlo E, Carli M, Barban M, Fassina A, Vettor R, Sicolo N (2008) Sudden death due to aortic rupture in acromegaly. Heart Vessels 23(1):71–74PubMedCrossRef
19.
go back to reference Yamamoto T, Kurosaka M, Sugimoto T (2001) A true aneurysm of the femoral artery in acromegaly. Clin Imaging 25(2):126–129PubMedCrossRef Yamamoto T, Kurosaka M, Sugimoto T (2001) A true aneurysm of the femoral artery in acromegaly. Clin Imaging 25(2):126–129PubMedCrossRef
20.
go back to reference Izgi C, Cevik C, Nugent K (2010) Annuloaortic ectasia and ascending aortic aneurysm as a cardiovascular manifestation of acromegaly. Cardiovasc Intervent Radiol 33(2):438–440 Izgi C, Cevik C, Nugent K (2010) Annuloaortic ectasia and ascending aortic aneurysm as a cardiovascular manifestation of acromegaly. Cardiovasc Intervent Radiol 33(2):438–440
21.
go back to reference Acqui M, Ferrante L, Matronardi L, d’Addetta R (1988) Alteration of the collagen type III/type I ratio and intracranial saccular aneurysms in GH-secreting hypophyseal adenomas. Ital J Neurol Sci 9(4):365–368PubMedCrossRef Acqui M, Ferrante L, Matronardi L, d’Addetta R (1988) Alteration of the collagen type III/type I ratio and intracranial saccular aneurysms in GH-secreting hypophyseal adenomas. Ital J Neurol Sci 9(4):365–368PubMedCrossRef
22.
go back to reference Paisley AN, O’Callaghan CJ, Lewandowski KC, Parkinson C, Roberts ME, Drake WM, Monson JP, Trainer PJ, Randeva HS (2006) Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly. J Clin Endocrinol Metab 91(11):4635–4640PubMedCrossRef Paisley AN, O’Callaghan CJ, Lewandowski KC, Parkinson C, Roberts ME, Drake WM, Monson JP, Trainer PJ, Randeva HS (2006) Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly. J Clin Endocrinol Metab 91(11):4635–4640PubMedCrossRef
23.
go back to reference Izgi C, Cevik C, Nugent K (2010) Annuloaortic ectasia and ascending aortic aneurysm as a cardiovascular manifestation of acromegaly. Cardiovasc Intervent Radiol 33(2):438–440PubMedCrossRef Izgi C, Cevik C, Nugent K (2010) Annuloaortic ectasia and ascending aortic aneurysm as a cardiovascular manifestation of acromegaly. Cardiovasc Intervent Radiol 33(2):438–440PubMedCrossRef
Metadata
Title
Prevalence of cerebral aneurysm in patients with acromegaly
Authors
Satoru Oshino
Akio Nishino
Tsuyoshi Suzuki
Hideyuki Arita
Akihiro Tateishi
Katsumi Matsumoto
Toshio Shimokawa
Manabu Kinoshita
Toshiki Yoshimine
Youichi Saitoh
Publication date
01-06-2013
Publisher
Springer US
Published in
Pituitary / Issue 2/2013
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-012-0404-x

Other articles of this Issue 2/2013

Pituitary 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.